Latham & Watkins Advises Edgewell Personal Care Company on US$340 Million Sale of Feminine Care Business to Essity

Edgewell Personal Care Company (NYSE: EPC) has announced that it has entered into a definitive agreement to sell its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for US$340 million. The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions, including the receipt of required regulatory approvals. Edgewell’s feminine care business includes Playtex®, Stayfree®, Carefree®, and o.b.®.

Latham & Watkins advised Edgewell Personal Care Company in the transaction with a corporate deal team led by New York partners Andrew Elken and Keith Halverstam, and Austin partner Rachel Ratcliffe Payne, with associates Denny Lee, David Lee, Samantha McGarvey, and Graham Core. Advice was also provided on intellectual property matters by counsel Arielle Singh, with associates Caroline Omotayo and Tyler Israel; on regulatory matters by Washington, D.C. partner Julia Hatcher, with associate Anna Dykema; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on executive compensation, employment, and benefits matters by Los Angeles/Orange County partner Michelle Carpenter, with associate Peter Dalmasy; on tax matters by Washington, D.C. partner Andrea Ramezan-Jackson, with associate Shiyi Parsons; on FDA regulatory matters by Washington, D.C. partner Elizabeth Richards and counsel Chad Jennings; on real estate matters by New York counsel Shira Bressler, with associate Marc Osian; on antitrust matters by Washington, D.C. partner Mandy Reeves and senior merger control attorney Matthew Piehl; with associate John Doyle; and on compliance matters by Washington, D.C. counsel Ruchi Gill, with associate Joelle Hageboutros.